The classical age indicators of the innominate have been the pubic symphysis and auricular surface. However, recently, the acetabulum has been highlighted as an indicator of adult age, with applicability in young, middle-aged, and older adults. The Rissech acetabular method was developed in a Portuguese population and tested in European and European-Americans, giving estimates within 10 years of age in more than 89% of the sample. The main goal of this paper is to test the Rissech acetabular method in a modern South American sample. The material used for the study was 184 women and 378 men from a Colombian-documented skeletal collection. The obtained morphological scores from the acetabulum were analyzed through the IDADE2 web page, a Bayesian statistical program that estimates a relative likelihood distribution for the target individuals, produces age estimates, and provides 95% confidence intervals. Results showed this method is useful in the modern Colombian population with an average absolute error of 10.63 years in females and 9.44 years in males. These errors are similar to those obtained in other European and North American samples when this method was performed and similar or lower than those obtained when the 3 classical aging methods (Suchey-Brooks, Buckberry-Chamberlain, and Lovejoy) were applied in the same collection (absolute error: 10.29 years ♀ and 9.05 years ♂ in Suchey-Brooks, 12.5 years ♀, and 12.17 years ♀ in Buckberry-Chamberlain, and 13.54 years ♀ and 10.99 years ♂ in Lovejoy). Although Rissech's method was developed in a Western European sample, the results of this study indicate its applicability in modern Colombian samples with reasonable accuracy.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1007/s00414-020-02422-w | DOI Listing |
Res Pract Thromb Haemost
January 2025
Division of Vascular Surgery, St. Michael's Hospital, Toronto, Ontario, Canada.
Background: Abdominal aortic aneurysm (AAA) is characterized by the proteolytic breakdown of the extracellular matrix, leading to dilatation of the aorta and increased risk of rupture. Biomarkers that can predict major adverse aortic events (MAAEs) are needed to risk stratify patients for more rigorous medical treatment and potential earlier surgical intervention.
Objectives: The primary objective was to identify the association between baseline levels of these biomarkers and MAAEs over a period of 5 years.
J Immunother Precis Oncol
February 2025
Department of Hematology and Medical Oncology, Emory University School of Medicine, Atlanta, GA, USA.
Introduction: Advanced penile squamous cell carcinoma (pSCC) is a rare and aggressive malignancy with a poor prognosis and an unmet need for biomarkers. We performed a retrospective evaluation of real-world efficacy, safety outcomes, and baseline inflammatory biomarkers in patients with advanced pSCC treated with immune checkpoint inhibitors (ICIs).
Methods: We performed a retrospective review of patients with advanced pSCC who received ICIs from 2012 to 2023 at the Winship Cancer Institute of Emory University in Atlanta, GA.
Inj Epidemiol
January 2025
Injury Prevention Research Center, University of Iowa, 145 N Riverside Dr., Iowa City, IA, 52242, USA.
Background: Motor vehicle crashes are the second leading cause of injury death among adults aged 65 and older in the U.S., second only to falls.
View Article and Find Full Text PDFJ Am Coll Surg
January 2025
Department of Surgery, The Ohio State University Wexner Medical Center and James Comprehensive Cancer Center, Columbus, OH.
Introduction: We aimed to investigate the geographic variation of Academic Medical Centers (AMCs) across different healthcare markets and the impact on surgical outcomes in nearby non-AMCs.
Methods: Patients who underwent major surgery between 2016 and 2021 were identified from the Medicare Standard Analytic Files. Healthcare markets were delineated using Dartmouth Atlas hospital referral regions.
J Vasc Surg
January 2025
Department of Vascular Surgery, Inselspital, Bern University Hospital, University of Bern, Switzerland.
Objective: Low-profile endografts have reported increased rates of limb graft occlusions. The INCRAFT stent graft system is an ultra-low profile endograft for the exclusion of infrarenal abdominal aortic aneurysms. Our aim was to report thromboembolic events (TE) in patients treated with the INCRAFT device and its association with risk factors.
View Article and Find Full Text PDFEnter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!